Avoro Capital Advisors LLC increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 0.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 2,858,888 shares of the biotechnology company’s stock after purchasing an additional 6,388 shares during the quarter. United Therapeutics comprises approximately 8.7% of Avoro Capital Advisors LLC’s […]
Vinva Investment Management Ltd grew its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 53.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,347 shares of the biotechnology company’s stock after acquiring an additional 2,914 shares during the […]
Vinva Investment Management Ltd boosted its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 53.6% in the fourth quarter, HoldingsChannel reports. The firm owned 8,347 shares of the biotechnology company’s stock after acquiring an additional 2,914 shares during the period. Vinva Investment Management Ltd’s holdings in United Therapeutics were worth $1,830,000 as of […]
Hsbc Holdings PLC boosted its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 6.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 94,693 shares of the biotechnology company’s stock after acquiring an additional 5,416 shares during the period. Hsbc Holdings PLC owned about 0.20% of […]
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) Director Martine A. Rothblatt sold 3,600 shares of the firm’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $275.78, for a total value of $992,808.00. Following the transaction, the director now owns 130 shares in the company, valued […]